June 27, 2007 (Press Release) --
At last a practical outlook that benefits our clients.”
-Nicola Dagg, Partner, Lovells, and inaugural board member of Pharmaceutcial Law Insight
Why you need Pharmaceutical Law Insight :
Be alert to the implications of important case decisions
For the compliance and management of pharmaceutical companies
Ensure your arguments are watertight
Benefit from expert interpretation and analysis of case law
Learn from the experience of experts
Save time and costly mistakes
Be armed with the latest facts
Provide best client advice in everyday practice
Concise opinions
Keep abreast of developments without extensive research
Inside Pharmaceutical Law Insight: News-bites, case comments and detailed analysis on :
Pharmaceutical IP; patents and trademarks
Advertising & marketing law
Regulation
Competition law
Data exclusivity
Licensing
Pricing & reimbursement
Why subscribe to Pharmaceutical Law Insight :
Keeping abreast of the latest developments in pharmaceutical law can take valuable time. Why not let Pharmaceutical Law Insight do the work for you! Each month it provides you with the latest cases and related developments in one accessible publication. Leading names in the industry will summarise and interpret the law to help you in your daily work.
Inside each issue you will find :
Strategic analysis and critical intelligence in a reader friendly format allowing you to stay abreast of cases and legislation relevant to the pharmaceutical market.
A comprehensive and concise round up of cases – saving you time and keeping you informed.
Case commentaries and opinion of leading experts in the field, giving you the rationale behind case decisions and changes in the law.
Consideration of these cases and IP legislation within the context of the global industry – providing you with a global view of product legislative impact in the UK and Europe.
“This new publication will be an invaluable tool for practitioners needing to keep up to date in this fast changing sector”
- Patrick Duxbury, Partner & Head of Life Sciences, Wragge & Co, and inaugural board member of Pharmaceutical Law Insight
Who should subscribe to Pharmaceutical Law Insight :
Pharmaceutical Companies: Head of Legal/In-house Counsel
Company Secretary
Licensing Manager
Business Development Director and IP Attorneys/lawyers
Law Firms: Lawyer/Attorneys working in IP
Competition or Life Sciences
Librarian and Professional Support Lawyers.
For more information, please visit:
http://www.bharatbook.com/detail.asp?id=10015
-Nicola Dagg, Partner, Lovells, and inaugural board member of Pharmaceutcial Law Insight
Why you need Pharmaceutical Law Insight :
Be alert to the implications of important case decisions
For the compliance and management of pharmaceutical companies
Ensure your arguments are watertight
Benefit from expert interpretation and analysis of case law
Learn from the experience of experts
Save time and costly mistakes
Be armed with the latest facts
Provide best client advice in everyday practice
Concise opinions
Keep abreast of developments without extensive research
Inside Pharmaceutical Law Insight: News-bites, case comments and detailed analysis on :
Pharmaceutical IP; patents and trademarks
Advertising & marketing law
Regulation
Competition law
Data exclusivity
Licensing
Pricing & reimbursement
Why subscribe to Pharmaceutical Law Insight :
Keeping abreast of the latest developments in pharmaceutical law can take valuable time. Why not let Pharmaceutical Law Insight do the work for you! Each month it provides you with the latest cases and related developments in one accessible publication. Leading names in the industry will summarise and interpret the law to help you in your daily work.
Inside each issue you will find :
Strategic analysis and critical intelligence in a reader friendly format allowing you to stay abreast of cases and legislation relevant to the pharmaceutical market.
A comprehensive and concise round up of cases – saving you time and keeping you informed.
Case commentaries and opinion of leading experts in the field, giving you the rationale behind case decisions and changes in the law.
Consideration of these cases and IP legislation within the context of the global industry – providing you with a global view of product legislative impact in the UK and Europe.
“This new publication will be an invaluable tool for practitioners needing to keep up to date in this fast changing sector”
- Patrick Duxbury, Partner & Head of Life Sciences, Wragge & Co, and inaugural board member of Pharmaceutical Law Insight
Who should subscribe to Pharmaceutical Law Insight :
Pharmaceutical Companies: Head of Legal/In-house Counsel
Company Secretary
Licensing Manager
Business Development Director and IP Attorneys/lawyers
Law Firms: Lawyer/Attorneys working in IP
Competition or Life Sciences
Librarian and Professional Support Lawyers.
For more information, please visit:
http://www.bharatbook.com/detail.asp?id=10015

Keeping abreast of the latest developments in pharmaceutical law can take valuable time. Why not let Pharmaceutical Law Insight do the work for you! Each month it provides you with the latest cases an
Email
Print
SPAM
LEAVE A COMMENT





